Todd E Simpson is Chief Financial Officer of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 93,292 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $21,363,868. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

TODD E SIMPSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2023
SELL
Sale (or disposition) back to the issuer
$21,363,868 $229.0 p/Share
93,292 Reduced 100.0%
0 Common Stock
Sep 21 2023
SELL
Open market or private sale
$16,520 $206.5 p/Share
80 Reduced 0.06%
128,723 Common Stock
Aug 31 2023
SELL
Open market or private sale
$439,190 $206.97 p/Share
2,122 Reduced 1.62%
128,803 Common Stock
Aug 29 2023
SELL
Open market or private sale
$99,910 $206.0 p/Share
485 Reduced 0.37%
130,925 Common Stock
Aug 28 2023
BUY
Grant, award, or other acquisition
-
1,225 Added 0.92%
131,410 Common Stock
Aug 16 2023
SELL
Sale (or disposition) back to the issuer
$679,902 $193.87 p/Share
3,507 Reduced 2.62%
130,185 Common Stock
Aug 15 2023
BUY
Grant, award, or other acquisition
-
14,746 Added 9.93%
133,692 Common Stock
Apr 10 2023
SELL
Open market or private sale
$11,314,527 $204.44 p/Share
55,344 Reduced 31.75%
118,946 Common Stock
Apr 10 2023
BUY
Exercise of conversion of derivative security
$2,566,301 $46.37 p/Share
55,344 Added 25.78%
159,310 Common Stock
Apr 06 2023
SELL
Open market or private sale
$50,023 $205.86 p/Share
243 Reduced 0.2%
118,946 Common Stock
Apr 05 2023
BUY
Grant, award, or other acquisition
-
609 Added 0.51%
119,189 Common Stock
Apr 01 2023
BUY
Grant, award, or other acquisition
-
1,395 Added 1.16%
118,580 Common Stock
Mar 09 2023
SELL
Open market or private sale
$7,559,811 $176.66 p/Share
42,793 Reduced 26.75%
117,185 Common Stock
Mar 09 2023
BUY
Exercise of conversion of derivative security
$1,938,522 $45.3 p/Share
42,793 Added 21.1%
159,978 Common Stock
Feb 27 2023
SELL
Open market or private sale
$3,650,600 $182.53 p/Share
20,000 Reduced 14.58%
117,185 Common Stock
Feb 16 2023
SELL
Open market or private sale
$6,391,360 $160.0 p/Share
39,946 Reduced 22.55%
137,185 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
$1,563,885 $39.15 p/Share
39,946 Added 18.4%
177,131 Common Stock
Aug 31 2022
SELL
Open market or private sale
$646,360 $154.41 p/Share
4,186 Reduced 2.96%
137,185 Common Stock
Aug 16 2022
SELL
Open market or private sale
$334,823 $170.22 p/Share
1,967 Reduced 1.37%
141,371 Common Stock
Aug 15 2022
BUY
Grant, award, or other acquisition
-
15,447 Added 9.73%
143,338 Common Stock
Apr 20 2022
SELL
Open market or private sale
$81,829 $144.32 p/Share
567 Reduced 0.44%
127,891 Common Stock
Dec 20 2021
SELL
Open market or private sale
$51,698 $149.85 p/Share
345 Reduced 0.27%
128,458 Common Stock
Nov 04 2021
BUY
Exercise of conversion of derivative security
$99,974 $46.37 p/Share
2,156 Added 1.65%
128,803 Common Stock
Nov 03 2021
SELL
Open market or private sale
$7,442,920 $185.0 p/Share
40,232 Reduced 24.11%
126,647 Common Stock
Nov 03 2021
BUY
Exercise of conversion of derivative security
$1,773,829 $44.09 p/Share
40,232 Added 19.43%
166,879 Common Stock

Also insider at

NLTX
Neoleukin Therapeutics, Inc. Healthcare
TES

Todd E Simpson

Chief Financial Officer
Bothell, WA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Track Activities on SGEN